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Summary 
Moderate alcohol consumption has been shown to protect against cardiovascular diseases. 
The association between alcohol consumption, especially types of alcoholic beverages, and 
venous thromboembolism (VTE) is less well described.  The aim of this study was to 
investigate the impact of alcohol consumption and different alcoholic beverages on risk of 
VTE.  Information on alcohol consumption were collected by a self-administrated 
questionnaire in 26 662 subjects, aged 25-97 years, who participated in the Tromsø Study, in 
1994-95.  Subjects were followed through September 1, 2007 with incident VTE as the 
primary outcome.  There were 460 incident VTE-events during a median of 12.5 years of 
follow-up.  Total alcohol consumption was not associated with risk of incident VTE. 
However, subjects consuming ≥3 units of liquor per week had 53% increased risk of VTE 
compared to teetotalers in analyses adjusted for age, sex, BMI, smoking, diabetes, cancer, 
previous cardiovascular disease, physical activity and higher education (HR: 1.53, 95% CI: 
1.00-2.33).  Contrary, subjects with a wine intake of ≥3 u/week had 22% reduced risk of VTE 
(HR: 0.78, 95% CI: 0.47-1.30), further adjustment for liquor and beer intake strengthened the 
protective effect of wine (HR: 0.53, 95% CI: 0.30-1.00).  Frequent binge drinkers (≥1/week) 
had a 17% increased risk of VTE compared to teetotallers (HR 1.17, 95% CI: 0.66-2.09), and 
a 47% increased risk compared to non-binge drinkers (HR 1.47, 95% CI: 0.85-2.54). In 
conclusion, liquor consumption and binge drinking was associated with increased risk of 
VTE, whereas wine consumption was possibly associated with reduced risk of VTE. 
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Introduction
Deep vein thrombosis (DVT) and pulmonary embolism (PE) together referred to as venous 
thromboembolism (VTE), is a common, multifactor disease, and a serious cause of morbidity 
and mortality (1, 2).  It affects 1-2 per 1000 adults each year (1, 3) and is the third most 
common cardiovascular disease (4).  Despite numerous known risk factors, still 25-50% of the 
events appear in the absence of predisposing factors (5).  In contrast to coronary artery disease 
(e.g. myocardial infarction), the incidence of VTE has not declined during the last decades 
(1).  Thus, it is vital to elucidate the impact of lifestyle factors on risk of VTE, in order modify 
the risk and reduce the disease burden related to VTE. 
In 2004, the World Health Organization (WHO) estimated that alcohol (ethanol) was 
consumed regularly by about two billion people worldwide (6).  Excessive alcohol intake and 
binge drinking are associated with major health risks and premature death.  On the other hand, 
alcohol affects several factors involved in haemostasis, such as inhibition of platelet 
aggregation (7), lowering of fibrinogen (8-10), factor VII (FVII), von Willebrand factor 
(vWF) and plasma viscosity (10), as well as increased levels of tissue plasminogen activator 
(tPA) (8, 9), and accumulating evidence indicates that moderate alcohol consumption may 
have a beneficial effect on arterial cardiovascular diseases (11, 12).
The association between alcohol consumption and VTE is less well described, and previous 
studies have been somewhat inconsistent.  Three prospective studies of elderly (13), young 
and middle-aged women (14, 15) and one large case-control study including both sexes (16) 
reported an inverse association between alcohol consumption and VTE.  In contrast, two other 
cohorts including male physicians (4) and middle-aged and elderly (17), as well as one case-
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control study of medical outpatients (18), found no association between alcohol consumption 
and VTE.  
Beer, wine and spirits may have different effects on VTE risk.  Only one of the previous 
studies, including elderly women only, had differentiated for type of alcoholic beverages (14). 
In the present study, we examined the impact of total alcohol consumption, as well as 
consumption of beer, wine and liquor separately, on the incidence of VTE in a large 
prospective cohort recruited from a general population. 
Materials and methods
Study population
Participants were recruited from the fourth survey of the Tromsø Study (conducted in 1994-
95), a single-centre prospective, population-based study, with repeated health surveys of the 
inhabitants of Tromsø, Norway.  All inhabitants aged >24 years were invited, and 27 158 
(77% of the eligible population) participated.  The study was approved by the regional 
committee for research ethics, and all participants gave written consent to participate.  
Subjects who did not consent to medical research (n = 201), subjects not officially registered 
inhabitants of the municipality of Tromsø at baseline (n = 43), subjects with a previous history 
of VTE (n = 48), and subjects who provided no information on any of the alcohol questions (n 
= 204) were excluded.  Thus, 26 662 subjects were included in the study, and followed from 
the date of enrolment to the end of the study period, September 1, 2007.
Assessment of alcohol consumption
Alcohol consumption habits were assessed through a self-administered questionnaire at 
baseline.  Subjects were asked whether they were teetotalers (yes/no). If no, subjects were 
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asked how many glasses of wine, beer or liquor they usually drank within a two week period. 
One unit corresponded to approximately 14 grams of alcohol. Total alcohol intake was 
categorized into teetotalers, <1 unit/week, 1-2 units/week, 3-6 units/week and ≥7 units/week. 
Beer, wine and liquor consumption were categorized into teetotalers, <1 unit/week, 1-2 
units/week and ≥3 units/week.  The questionnaire did not provide information on former 
drinking among teetotalers.  A subpopulation of 21 382 participants (all subjects aged <70 
years) were also asked how often during the past 12 months they had been drinking alcohol 
corresponding to at least 5 small bottles of beer, a bottle of wine or a quarter bottle of liquor 
(binge drinking). Binge drinking was categorized into teetotalers, never (subjects who were 
not teetotalers and reported no binge drinking), a few times, 1-2 times per month, and once a 
week or more.
Other measurements
Height and weight were measured with subjects wearing light clothing and no shoes.  Body 
mass index (BMI) was calculated as weight in kilograms, divided by the square of height in 
meters (kg/m²).  Information on self-reported diabetes, prior cardiovascular disease 
(myocardial infarction, angina pectoris or stroke), current daily smoking 
(pipe/cigar/cigarettes), hormone therapy (self-reported current use of estrogen 
supplementation or oral contraceptives), higher education (education at college /university 
level) and physical activity (≥1 hour per week) during leisure time was collected through a 
self-administered questionnaire.  Information on pre-baseline cancer was obtained from the 
Norwegian Cancer Registry. 
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Venous thromboembolism ascertainment
All first lifetime events of VTE during follow-up were identified by searching the hospital 
discharge diagnosis registry, the autopsy registry, and the radiology procedure registry at the 
University Hospital of North Norway, as previously described (19).
The medical records for each potential VTE-case were reviewed by trained personnel.  For 
subjects derived from the hospital discharge diagnosis registry and the radiology procedure 
registry, an episode of VTE was verified and recorded as a validated outcome when all four of 
the following criteria were fulfilled: (i) objectively confirmed by diagnostic procedures 
(compression ultrasonography, venography, spiral-computed tomography (CT), perfusion-
ventilation scan, pulmonary angiography or autopsy); (ii) the medical record indicated that a 
physician had made a diagnosis of DVT or PE; (iii) signs and symptoms consistent with DVT 
or PE were present; (iv) therapy with anticoagulants (heparin, warfarin, or similar agent) 
thrombolytics, or vascular surgery were required.  For subjects derived from the autopsy 
registry, a VTE-event was recorded as an outcome when the autopsy record indicated VTE as 
a cause of death or as a significant condition.
Statistical analyses
For each participant, person-years of follow-up were accrued from the date of enrolment in 
the Tromsø study (1994-95), to the date a VTE-event was first diagnosed, the date the 
participant died or moved from the municipality of Tromsø, or to the end of the study period, 
September 1, 2007.  Subjects who moved from the municipality of Tromsø or died during 
follow-up were censored from the date of death or migration.
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Statistical analysis was carried out using SPSS version 17.0 (SPSS Inc.Chicago, IL, USA). 
The significance level was 0.05.  Cox proportional hazards regression models were used to 
estimate age- and sex-adjusted, and multivariable-adjusted, hazard ratios (HRs) for VTE by 
levels of total alcohol consumption, and levels of beer, wine and liquor consumption 
separately.  The lowest consumption level was used as the reference level in each model.  In 
the multivariable model 2, HRs were adjusted for age, sex, BMI, smoking, diabetes, cancer, 
history of cardiovascular diseases, educational level and physical activity.  In model 3, 
categories of beer, wine and liquor were added to model 2, resulting in a model where the 
types of alcoholic beverages were adjusted for one another in addition to all the covariates 
from model 2.  The proportional hazard assumption was verified by evaluating the parallelism 
between the curves of the log-log survivor function for categories of alcohol consumption. 
Results
There were 460 validated incident VTE-events during 288 730 person-years of follow-up, and 
the overall crude incidence rate was 1.60 per 1000 person-years (95% CI: 1.46-1.75). 
Characteristics of the patients at the time of the VTE event are shown in Table 1.  
Baseline characteristic across levels of weekly alcohol intake is shown in Table 2. The 
teetotalers were older and had a higher proportion of concomitant diseases (diabetes, cancer 
and prior CVD).  The proportion of males, smokers, higher educated and physically active 
subjects increased across increasing levels of alcohol consumption (table 2). 
There was no association between total alcohol consumption and risk of incident VTE (p for 
trend across categories: 0.7) (Table 3).  Regular alcohol consumption ≥7 u/week was 
associated with a HR of 0.98 (95% CI: 0.61-1.58) compared to teetotalers.  
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Hazard ratios for venous thromboembolism (VTE) by different types of alcoholic beverages 
are shown in table 4.  Beer intake was not associated with risk of VTE (p for trend 0.5). 
Multivariable HR for ≥3 u/week versus teetotalers was 0.97 (95% CI: 0.62-1.57) (model 2, 
table 4). However, when adjusted for wine and liquor intake, a beer consumption of ≥3 
u/week tended to be negatively associated with VTE (HR: 0.65, 95% CI: 0.36-1.19) (model 
3).  A wine consumption of ≥3 u/week was associated with a 22% reduced risk of VTE (HR: 
0.78, 95% CI: 0.47-1.30), though the result was not statistically significant.  Further 
adjustment for beer and liquor intake strengthened the inverse association, and revealed a 
47% reduced risk of VTE (HR: 0.53, 95% CI: 0.30-1.00) (model 3, table 4).  Contrary, liquor 
consumption was significantly associated with increased risk of VTE (p for trend 0.04). 
Subjects with a liquor intake of more than three units per week had a 53% (Multivariable HR: 
1.53, 95% CI: 1.00-2.33), increased risk of VTE compared to teetotalers after adjustment for 
age, sex, BMI, smoking, diabetes, cancer, history of CVD, education level and physical 
activity (model 2, table 4).  Further adjustments for wine and beer intake (model 3), revealed 
an even stronger effect of liquor on VTE (HR 2.03, 95% CI: 1.15-3.59). 
Table 5 shows the association between frequency of binge drinking and VTE among subjects 
aged <70 years.  Binge drinking was associated with increased risk of VTE (p for trend across 
categories: 0.07).  Subjects who reported a binge drinking frequency of once a week or more 
had an age- and sex-adjusted 1.2-fold (HR: 1.20, 95% CI: 0.70-2.09) increased risk of VTE 
compared to teetotalers, and a 63 % increased risk compared to non-binge drinkers who were 
not teetotalers (HR: 1.63, 95% CI: 0.96-2.77). Further adjustments for BMI, smoking, 
diabetes, cancer, history of CVD, education level and physical activity attenuated the risk 
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estimates (HR: 1.17, 95 % CI: 0.66-2.09, and HR: 1.47, 95% CI: 0.85-2.54, respectively) 
(table 5).
In order to investigate whether liquor or wine consumption was related to specific drinking 
patterns among subjects in our study, we conducted a cross tabulation between beverage 
categories and binge drinking. Among those in the upper category of liquor (≥3u/week) 36% 
reported a binge drinking frequency of once a week or more. The corresponding numbers for 
wine drinkers was 25% and 29% for beer drinkers (≥3u/week) 
Discussion
In the present study, liquor consumption and binge drinking was associated with increased 
risk of VTE.  Subjects who drank three or more units of liquor per week had a 53% higher 
risk of VTE compared to teetotalers.  Binge drinking at a frequency of once per week or more 
was associated with a 47% increased risk of VTE compared to non-binge drinkers who were 
not teetotalers.  In contrast, wine consumption of three or more units per week was associated 
with a 22% reduced risk of VTE. The risk estimates associated with liquor intake and wine 
intake were even stronger after adjustment for the other types of alcoholic beverages; liquor 
drinkers (≥3u/week) had 103% increased risk of VTE, whereas wine drinkers (≥3u/week) had 
47% reduced risk compared to teetotalers.  The latter findings suggest that the observed 
harmful effect of liquor was not caused by absence of wine intake, and beneficial effect of 
wine was not caused by absence of liquor intake. Beer consumption showed a possible 
negative association with VTE only after adjustments for the other types of alcoholic 
beverages.   
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So far, only The Iowa Women’s Health Study (14) has reported on the impact of different 
types of alcoholic beverages on VTE risk.  In contrast to our findings, they reported that the 
observed protective effect of alcohol was significant for beer consumption only, and not for 
wine or liquor.  The discrepancy between these studies may to some extent be explained by 
differences in cut off values for alcoholic beverages (≥1u/week vs. ≥3u/weeks) and study 
populations (elderly women vs. general population of both genders) as drinking patterns may 
differ both among genders and age groups.  
Previous studies have shown somewhat diverging results on the relation between alcohol and 
risk of VTE.  A prospective cohort of elderly from three different communities in the US (13), 
found that light to moderate alcohol consumption was associated with a decreased risk of 
VTE.  The MISS study (15), a large Swedish cohort of middle-aged women, found that 
women with moderate alcohol consumption had lower risk of VTE.  In contrast, the LITE-
study, a prospective cohort including middle-aged and elderly subjects from a general 
population (17), found no association between alcohol consumption and VTE.  Moreover, a 
prospective study, including male physicians only (4), found that alcohol was protective 
against coronary heart disease, but not associated with stroke or VTE.  In a large case-control 
study of Dutch men and women (16), subjects with a previous history of VTE had lower 
alcohol intake, and a concomitant decrease in fibrinogen levels in alcohol consumers 
compared to abstainers was suggested as a plausible explanation for the decreased risk of 
VTE.  In contrast, another case-control study conducted in France, found no association 
between alcohol and VTE (18).  In our study, total alcohol intake showed no association with 
VTE.  However, this was probably explained by the fact that risk estimates for wine and 
liquor consumption pointed in opposite directions. 
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Previous studies investigating the impact of alcohol types on arterial cardiovascular diseases 
(CVD) have proposed a superior antithrombotic effect of wine compared to beer and liquor 
(20, 21).  Accordingly, wine was inversely related to VTE in our study, whereas liquor was 
associated with a considerable increase in risk of VTE.  The differential impact of alcoholic 
beverages on risk of VTE may suggest that other components of wine, rather than ethanol 
itself, may be responsible for the beneficial effect.  Resveratrol, a polyphenol found in the 
skin of grapes, promotes antithrombotic effects (22) such as suppression of aberrant 
expression of tissue factor (11, 22), suppression of platelet aggregation (7) and induction of 
platelet disaggregation in preformed thrombi (23).  A possible mechanism for the apparent 
disadvantage of liquor consumption may be related to the strong association between heavy 
liquor consumption and the tendency to binge drinking.  Binge drinking is known to 
contradict the beneficial effect of moderate alcohol consumption on the risk of CVD (12, 24) 
and to exert an unfavorable effect on the haemostatic system by inhibiting the fibrinolytic 
system (10, 25). Moreover, a possible wine preference in non-binge drinkers may explain the 
observed risk differences between frequent binge drinkers, non-binge drinkers and teetotalers 
(table 5).
Several studies have addressed the issue that the association between moderate alcohol 
consumption in general, and wine in particular, and the decreased risk of CVD may be due to 
a selection of subjects sharing this moderate drinking pattern and wine preference (26, 27). 
Moderate wine drinkers generally have higher education (26), are more physically active and 
have a lower BMI, a better diet and smoke less frequently (27), compared to the non-drinkers, 
heavy-drinkers and those who choose beer or liquor over wine. Norwegian national statistics 
show that people with beer and wine preference have higher educational level and income, 
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while the opposite trend exist for liquor drinkers (28). To prevent confounding by other 
lifestyle factors we adjusted for age, sex, BMI, diabetes, cancer, previous CVD, smoking, 
physical activity and educational level.  The tendency of a decreased risk associated with 
wine, and the increased risk associated with liquor and binge drinking remained after the 
adjustments.  Further adjustments for estrogen use (women only) did not affect our findings. 
The prospective design, large number of participants recruited from a general population with 
high attendance rate, long-term follow-up, and validated VTE-events are the major strengths 
of this study.  All hospital care and radiological imaging in the region is exclusively provided 
by a single hospital, which enhances the completeness of the VTE registry.  The study also 
has some limitations.  Several risk factors are modifiable, and alcohol consumption habits 
may change over time.  This type of non-differential misclassification, generally leads to 
underestimation of the true association.  However, according to Statistics Norway, the 
consumption of wine increased significantly in the Norwegian population during the follow-
up period, while beer and liquor consumption was more or less unchanged (29). Information 
of alcohol consumption habits was collected through self-administered questionnaires, and the 
reliability and validity of this type of assessment can be questioned.  However, self-reported 
intake of alcohol was associated with expected and previously reported beneficial frequency 
of CVD (11, 12) and level of education (30). A previous validation study (31) showed that 
assessment of alcohol intake from a food frequency questionnaire (FFQ) was suitable for 
studying diet-disease associations. Unfortunately we did not have information on former 
drinkers. The alcohol consumption was fairly low in our study population compared to some 
of the previous studies from other countries.  This is in agreement with the WHO Global 
Status Report on Alcohol which reported that the intake of pure alcohol in Norway was about 
half of that in the Netherlands, Italy and the US, and only a third of that in France, during the 
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period 1993-97 (6).  The low alcohol consumption limited our possibilities to give a finer 
classification of amount of alcohol and explore the impact of heavy drinking on VTE. 
However, in spite of generally low overall alcohol consumption in our population cohort, we 
detected a distinct impact of alcohol type and drinking pattern (binge drinking) on the risk of 
VTE. 
In conclusion, our findings suggest a harmful effect of liquor (≥3 units/week) and binge 
drinking, and a beneficial effect of wine and possibly beer consumption on the risk of VTE. 
Further studies are needed to establish whether these findings are due to constituents other 
than ethanol in wine and beer, if it is due to ethanol itself in liquor, the unfavorable binge 
drinking pattern associated with heavy liquor intake, or other unrecognized health-related 
confounders associated with types of alcoholic beverages.
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Sex (males) 47.4 (218)
Deep vein thrombosis 64.1 (295)
Pulmonary embolism 35.9 (165)













†No provoking factor present at the time of diagnosis
‡Estrogen = hormone replacement therapy or oral contraceptives
§Heredity = VTE in first degree relative before aged 60 years
||Other diseases within the previous year (e.g. myocardial infarction, ischemic stroke, hearth 
failure and chronic obstructive pulmonary disease).
#Immobilization = Bed rest>3 days, wheelchair, plaster cast, air/automobile travel >4h <14 
days prior to event.
±Other specific provoking factors described by a physician in the medical record (e.g. 
intravascular catheter).
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Table 2. Baseline characteristics across levels of average alcohol consumption (u/week). 
The Tromsø Study, 1994-2007. Values are means (SD) or percentages (numbers).
Alcohol consumption (u/week)
Teetotaler <1 1-2 3-6 ≥7
n 3511 7524 4678 9126 1823
Person years 35637 81795 51564 100044 19690
Age (years) 58±17 49 ± 16 44 ± 13 43 ± 12 44 ± 12
Sex (% males) 32.5 (1140) 35.9 (2703) 42.0 (1967) 58.8 (5362) 82.1 (1496)
BMI (kg/m2) 26.2±4.6 25.3 ± 4.2 24.8 ± 3.5 24.8 ± 3.4 25.4 ± 3.5
Smoking (%) 20.8 (731) 34.9 (2627) 33.8 (1582) 40.9 (3728) 51.0 (930)
Diabetes (%) 4.9 (172) 1.8 (138) 1.5 (68) 0.9 (85) 0.8 (15)
Cancer (%) 5.8 (203) 3.5 (267) 2.0 (94) 1.9 (175) 1.5 (28)
CVD (%)* 15.4 (542) 7.8 (590) 4.2 (196) 3.8 (344) 5.0 (91)
Education (%)† 14.2 (499) 21.0 (1581) 34.5 (1612) 37.9 (3459) 41.1 (749)
Physical activity (%) 17.1 (601) 23.7 (1783) 32.1 (1503) 38.2 (3485) 36.9 (672)
Hormone therapy (%)‡ 6.9 (163) 11.3 (546) 13.9 (377) 16.4 (616) 17.4 (57)
*Self-reported history of myocardial infarction, angina pectoris or stroke
†Education at university/college level
‡ Hormone therapy: Self-reported current use of estrogen supplementation or oral 
contraceptives. Percentage of women. 
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Table 3. Hazard ratios (HR) with 95% confidence interval (CI) for venous 











Teetotaler 35 637 108 1.00 (reference) 1.00 (reference)
<1 81 795 135 0.85 (0.66-1.10) 0.89 (0.69-1.16)
1-2 76 051 107 1.00 (0.75-1.33) 1.10 (0.82-1.38)
3-6 59 851 69 0.93 (0.67-1.29) 0.98 (0.70-1.39)
≥7 19 690 25 0.94 (0.59-1.49) 0.98 (0.61-1.58)
            p for trend 1.0 0.7
*Model 1: Adjusted for age and sex
†Model 2: Adjusted for age, sex, body mass index, smoking, diabetes, cancer, history of CVD, 
education level and physical activity.
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Table 4. Hazard ratios (HR) with 95% confidence interval (CI) for venous 













Teetotaler 35 637 108 1.00 (reference) 1.00 (reference) 1.00 (reference)
<1 158 750 263 0.92 (0.72-1.16) 0.97 (0.76-1.23) 0.73 (0.50-1.07)
1-2 67 905 61 0.78 (0.55-1.10) 0.82 (0.58-1.18) 0.59 (0.36-0.97)
≥3 26 438 28 0.98 (0.62-1.54) 0.97 (0.62-1.57) 0.65 (0.36-1.19)
            p for trend 0.4 0.5 0.7
Wine (u/week)
Teetotaler 35 637 108 1.00 (reference) 1.00 (reference) 1.00 (reference)
<1 168 911 253 0.91 (0.72-1.16) 0.95 (0.75-1.22) 0.73 (0.51-1.06)
1-2 65 173 79 0.92 (0.68-1.25) 0.99 (0.72-1.36) 0.73 (0.46-1.14)
≥3 19 009 20 0.73 (0.45-1.19) 0.78 (0.47-1.30) 0.53 (0.30-1.00)
            p for trend 0.3 0.5 0.1
Liquor (u/week)
Teetotaler 35 637 108 1.00 (reference) 1.00 (reference) 1.00 (reference)
<1 185 293 229 0.83 (0.65-1.05) 0.88 (0.69-1.13) 1.10 (0.75-1.62)
1-2 53 317 90 1.11 (0.82-1.50) 1.18 (0.86-1.61) 1.53 (0.96-2.44)
≥3 14 483 33 1.48 (0.98-2.24) 1.53 (1.00-2.33) 2.03 (1.15-3.59)
            p for trend 0.07 0.04 0.001
*Model 1: Adjusted for age and sex
†Model 2: Adjusted for age, sex, body mass index, smoking, diabetes, cancer, history of CVD, 
education level and physical activity.
‡Model 3: Categories of beer, wine or liquor added to model 2 making the types of alcoholic 
beverages adjusted for one another (i.e. beer is adjusted for wine intake, liquor intake age, 
sex, body mass index, smoking, diabetes, cancer, history of CVD, education level and 
physical activity).  
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Table 5. Hazard ratios (HR) with 95% confidence interval (CI) for venous thromboembolism (VTE) by frequency of binge drinking in 
subjects <70 years old (n=21 382).  The Tromsø Study, 1994-2007.







HR (95 % CI)
Model 2†
HR (95 % CI)
Model 1*
HR (95 % CI)
Model 2†
HR (95 % CI)
Teetotaler 25 833 50 1.00 (reference) 1.00 (reference) - -
Never 62 722 68 0.74 (0.51-1.07) 0.81 (0.56-1.18) 1.00 (reference) 1.00 (reference)
A few times per year 91 220 98 0.97 (0.67-1.39) 1.03 (0.72-1.50) 1.32 (0.96-1.82) 1.30 (0.94-1.80)
1-2 times per month 43 703 45 1.10 (0.71-1.70) 1.11(0.71-1.76) 1.15 (1.01-2.25) 1.42 (0.94-2.14)
≥Once a week 13 386 19 1.20 (0.70-2.09) 1.17 (0.66-2.09) 1.63 (0.96-2.77) 1.47 (0.85-2.54)
P for trend 0.07 0.3 0.02 0.2
*Model 1: Adjusted for age and sex
†Model 2: Adjusted for age, sex, body mass index, smoking, diabetes, cancer, history of CVD, education level and physical activity.
What is known about this topic
- Previous studies on the relation between alcohol consumption and VTE have shown 
diverging results.
- The association between types of alcoholic beverages and venous thromboembolism 
(VTE) is not well described.
What this paper adds
- There was no association between total alcohol consumption and VTE. However, the 
risk estimates for VTE by different types of alcoholic beverages pointed in opposite 
directions.
- Liquor consumption and binge drinking was associated with increased risk of VTE, 
respectively, whereas wine consumption was associated with reduced risk of VTE.
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